A variety of methods have been developed and modified to facilitate the cloning of polymerase chain reaction (PCR) products directly into a plasmid (1, 4, 6, (9) (10) (11) . However, there are limitations in practice, including the low frequency of correct clones, the expense of commercially available cloning systems and the need to add sequence or other modifications to primers to enable cloning. The more recent development of long and accurate PCR (LA-PCR) offers the ability to isolate much longer products (2) . Using this technique, the vast majority of full-length mRNA transcripts can be easily amplified by reverse transcription (RT) and LA-PCR. In addition, since the coding region for the majority of mammalian genes is contained within approximately 20 kb or less of genomic DNA (8) , this technology can be used to rapidly obtain genomic sequence corresponding to known cDNAs. However, these and other applications of PCR are limited by the inability to efficiently clone amplified products.
To generate an intron-exon map for a novel human cDNA, we used LA-PCR and cDNA-derived primers to amplify a 5.0-kb genomic DNA fragment that contained two-thirds of the protein coding region. Our efforts to clone this 5.0-kb fragment into a plasmid were not successful using four different published techniques (1, 6, 9, 11, 12) , two of which were available as commercial kits. Similarly, introduction of restriction sites into the 5 ′ end of primers did not facilitate cloning. These poor results were attributed to several factors. First, the low efficiency of cloning seems exacerbated for longer PCR products. Second, the lack of knowledge of sequence between the primers complicates addition of restriction sites to the ends of the primers. Finally, in several cases, LA-PCR failed after the addition of a 5 ′ -end sequence to the longer primers required for this technique.
We modified a procedure recommended by vendors of commercial cDNA synthesis kits to enable addition of Eco RI complementary ends to double-stranded, blunt-ended cDNA (5). The approach requires no prior knowledge of the DNA sequence between the primers, requires no restriction enzyme digestion of PCR products and uses only the enzymes T4 polynucleotide kinase, T4 DNA ligase and Klenow fragment of DNA Polymerase I (all enzymes were from New England Biolabs, Beverly, MA, USA). In brief, after rendering PCR product ends blunted and 5 ′ phosphorylated, single adaptors are ligated to each end. The adaptors are then 5 ′ phosphorylated in the same tube, and free adaptors are separated from the Eco RI-compatible PCR product using a spin column. Products of 1.4 or 5.0 kb were amplified from 50-250 ng genomic DNA or from a cDNA product resulting from RT of 3 µ g of total RNA. PCR primers were typically 30 nucleotides in length. PCR conditions were as described (2) and utilized Klentaq and Pfuor, alternatively, r Tthpolymerase and Vent ® DNA polymerase (3). Typical PCR profiles were 1 min at 95°C, 2 min at 62°C and 4 min at 68°C for the first cycle, followed by 10 s at 95°C, 2 min at 62°C and 4 min at 68°C for the remaining 35 cycles. Finally, reactions were incubated for 10 min at 72°C. Optimal conditions were achieved by varying the annealing temperature and by titration of EDTA (to vary free Mg 2+ ). EDTA was added in 0.5-mM increments, and the optimal EDTA concentration in our reactions was 1.5 mM (Klentaq + Pfureaction) or 1.0 mM (r Tth+ Vent reaction). The product was purified using glass powder (GENECLEAN ® II, Bio 101, La Jolla, CA, USA).
To render the ends blunt and 5 ′ phosphorylated, purified PCR products (ca. 1-5 µ g) were treated with T4 polynucleotide kinase and either Klenow fragment or DNA polymerase I as described (12). The purified PCR products were incubated for 1 h at 37°C in 100 µ L reaction mixture containing 50 mM Tris-HCl (pH 7.5), 10 mM MgCl 2 , 1 mM dithiothreitol (DTT), 50 µ g/mL bovine serum albumin (BSA), 1 mM ATP, 200 µ M each dNTP and 10 U of T4 kinase and either 10 U of DNA polymerase I or 5 U of Klenow fragment. Reactions were purified by phenol/chloroform extractions and ethanol precipitation. The polished and kinased PCR product was dissolved in 5.5 µ L sterile water.
The Eco RI adaptors are 5 ′ blunt-end phosphorylated and 5 ′cohesive-end non-phosphorylated (Stratagene, La Jolla, CA, USA). In addition, the adaptors contain an 8-bp Not I site that allows the release of cloned inserts by enzyme digestion. The adaptor sequence is:
The PCR product was ligated to adaptors in a 10-µ L reaction containing 1.5 µ L of Eco RI adaptors (500 ng/ µ L), 5.5 µ L of polished and kinased PCR product, 1 µ L of 10 ×TM buffer (500 mM Tris-HCl, pH 7.5, 70 mM MgCl 2 , 10 mM DTT), 1 µ L of 10 mM ATP and 1 µ L of T4 DNA ligase (6 Weiss U/ µ L). After incubation overnight at 8°C, the ligase was heat-inactivated for 30 min at 70°C, and the reaction was placed on ice.
The reaction volume was brought to 20 µ L by addition of 1 µ L of 10 ×TM buffer (see above), 2 µ L of 10 mM ATP, 6 µ L of sterile water and 1 µ L of T4 polynucleotide kinase (10 U/ µ L). The kinase reactions were incubated for 30 min at 37°C, terminated by heat inactivation for 30 min at 70°C and then placed on ice.
To remove unligated adaptors, the adaptor-ligated PCR products were diluted to 50 µ L and mixed with 5 µ L of 10 × STE (1.0 M NaCl, 200 mM TrisHCl, pH 7.5, 100 mM EDTA). A 1-mL Sephacryl ® S-400 HR spin column (Sigma Chemical, St. Louis, MO, USA) was prepared in a tuberculin syringe using silanized glass wool as column support. A 15-mL conical tube held the syringe during centrifugation. The storage buffer was removed by centrifugation (all centrifugations were done at 400 × g for 2 min), and the column was pre-equilibrated in 1 × STE by filling and centrifugating three times. PCR product in 1 ×STE was added to the dry column bed, and the loaded volume was recovered by centrifugation (fraction 1). A single wash of 60 µ L of 1 ×STE was added to the dry column bed, and fraction 2 was collected by Benchmark s centrifugation. PCR products >500 bp were recovered by pooling fractions 1 and 2. To remove residual kinase, the eluate was purified by phenol/chloroform extractions and ethanol precipitation. cDNA synthesis protocols (e.g., Stratagene) typically recommend ligation of this material directly to a vector. In our experiments, PCR products were briefly separated by agarose gel electrophoresis (12 V/cm) and eluted using a Micron ® -30 Concentrator (Amicon, Beverly, MA, USA) (7), although this purification step may not be necessary.
The adaptor-linked PCR product (10-80 ng) was ligated to pBluescript ® KS(+) vector (Stratagene), previously treated with Eco RI and dephosphorylated with calf intestinal alkaline phosphatase. The ligated products were introduced into E. coli XL-1 blue cells (Stratagene) by electroporation. The transformed cells were plated in the presence of 5-bromo-4-chloro-3-indolyl-β -D -galactopyranoside (X-gal) and isopropyl-β -D -thiogalactopyranoside (IPTG) to allow for blue/white selection. While both 1.4-kb and 5.0-kb inserts significantly increased the frequency of white colonies compared with a vector-only control (not shown), the 1.4-kb product induced more white colonies (ca. 2000-6000 colonies per ligation) than the 5.0-kb insert (ca. 200-400 colonies per ligation). Usually, 10-20 bacterial clones were analyzed from each transformation by preparation of plasmid DNA and restriction enzyme digestion. In three different cloning experiments involving multiple independently generated PCR products, 40%-100% of the selected white colonies generated the correct insert (Table 1) . While the frequency of correct clones was higher for the smaller fragment, the correct insert was found for the 5.0-kb product in ≥ 40% of characterized clones in each experiment. For the 1.4-kb product, the high frequency of correct clones enabled sequence analysis of material obtained by scraping cells directly from the dish and preparing plasmid DNA.
Many single clones were also analyzed by DNA sequencing. Clones generated after polishing the PCR product with DNA polymerase I holoenzyme frequently contained small deletions at the vector junction, presumably due to the intrinsic 5 ′ -3 ′ exonuclease activity of this enzyme. Therefore, if accurate junctions are required (e.g., to maintain an open reading frame), we recommend using Klenow or T4 DNA polymerase during the polishing step. Alternatively, if precise junctions are not essential (e.g., for intron-exon mapping), the DNA polymerase I 5 ′ -3 ′ exonuclease activity may favorably affect the cloning efficiency as described (12). The frequency of base mis-incorporation in LA-PCR products using Klentaq and Pfupolymerases appeared low as reported (2). In our hands, a newer LA-PCR protocol that was optimized for yield by using r Tthand Vent polymerases and a buffer containing glycerol and dimethy sulfoxide (DMSO) resulted in a significant reduction in fidelity (3).
The improved efficiency of this cloning approach over previously published methods may be attributed to several factors. The large molar excess of small adaptors compared with larger plasmid vectors favors successful blunt-end ligation to PCR product. Perhaps due to thermal damage during synthesis (2), PCR products are notoriously bad substrates for enzymatic reactions. The method detailed here bypasses the requirement for more complex enzymatic reactions (e.g., restriction enzyme digestion or treatment with T4 DNA polymerase to generate 5 ′ overhangs), requiring only simple reactions involving the very extreme end of the fragments (i.e., phosphorylation by T4 kinase or ligation to adaptor). Finally, the sequence independence of the method and the lack of requirement for 5 ′ -end modification of primers makes this method truly general. The method will likely allow cloning of fragments larger than 5 kb, although ligation to other vectors such as bacteriophage lambda may be preferable for fragment sizes >5-10 kb. Ligation to single adaptors represents a useful approach to allow efficient, inexpensive cloning of amplified products. 
Optimized Conditions for Cloning PCR Products Into an XcmI T-Vector
BioTechniques 22: 40-44 (January 1997) Strategies for the direct cloning of polymerase chain reaction (PCR) products take advantage of the terminal transferase activity of TaqDNA polymerase. Under standard PCR conditions, Taq polymerase preferentially adds an A residue to the 3 ′ end of the PCR product (3). Thus, PCR products can be cloned directly into DNA vectors that contain complementary 3 ′ T overhangs (T-vector). T-vectors have been created by inserting DNA linkers that contain two adjacent restriction sites for either Hph I (7), Asp EI (5) or XcmI (2, 4, 6, 9) . When these vectors are digested with the corresponding restriction enzyme, the vector molecule is linearized, and each end has a 3 ′ T overhang. If digestion of these T-vectors is incomplete, then the vector can re-circularize in the ligation reaction leading to a high background of nonrecombinant transformants. To reduce the number of nonrecombinant transformants, the T-vectors were either treated with phosphatase before ligation (2, 5) or were treated with the restriction enzyme during the ligation (4). These additional steps may be problematic because phosphatase treatment of the vector requires an additional step and reduces ligation efficiency; adding a restriction enzyme to the ligation reaction prevents the cloning of PCR products that contain that restriction site.
In this report, the conditions for cloning PCR products into an XcmI Tvector were optimized so that the need to reduce the nonrecombinant background was eliminated. We observed that the percentage of recombinant transformants was greatly increased when the PCR product was purified before the ligation reaction and when a 20-fold molar excess of the purified PCR product to theXcmI T-vector was used in the ligation reaction.
To prepare the vector, the XcmI Tvector, pKRX, was constructed by inserting a 36-bp linker that contains two XcmI sites (Figure 1 ) into the Eco RI and Sal I sites of pBSIISK(+) (Stratagene, La Jolla, CA, USA). The polylinker region of this vector was sequenced from both directions to verify that the Eco RI and Sal I sites were regenerated and the lac Z reading frame was maintained. The resulting vector is 2977 bp in length. pKRX (5 µ g) was treated with 10 U of XcmI (New England Biolabs, Beverly, MA, USA) in a 50-µ L reaction that contained the recommended buffer plus 100 µ g/mL bovine serum albumin (BSA) at 37°C for at least 4 h, purified (QIAquick ™; Qiagen, Chatsworth, CA, USA), eluted in 50 µ L TE buffer (10 mM Tris-HCl, pH 7.5, 1 mM EDTA), quantified with an ultraviolet (UV)/visible (VIS) spectrophotometer (Beckman Instruments, Fullerton, CA, USA) using a conversion factor for optical density of 1 OD 260 = 50 ng/ µ L, diluted to 50 ng/ µ L with TE and stored at 4°C.
To prepare the PCR product for this study, a 606-bp product was amplified from total yeast DNA using a forward (nucleotide [nt] 895, 5 ′ -CGCATCTAT -GCACTCATCAG) and a reverse (nt 1500, 5 ′ -GGGCTATGCTAATCCCA-TAG) primer derived from the yeast gene SP011 (1) . PCR was performed in the recommended buffer (PerkinElmer, Norwalk, CT, USA) using 100 pmol of each primer, 40 ng of DNA template and 2.5 U of Taq DNA polymerase in a total reaction volume of 100 µ L. Amplification was performed in a thermal cycler equipped with a "hot-bonnet" (MJ Research, Watertown, MA, USA) as follows: 2 min at 94°C, then 35 cycles of 30 s at 94°C, 30 s at 55°C, 30 s at 72°C and an additional 7 min at 72°C after the last cycle. The PCR product was purified and quantified as above.
For DNA ligation and transformation, ligation reactions were performed in the recommended buffer (Boehringer Mannheim, Indianapolis, IN, USA) and contained 50 ng of vector DNA, the indicated amount of PCR product and 1 U of T4 DNA ligase in a total reaction volume of 10 µ L. After incubation at 16°C for at least 6 h, an aliquot of each ligation reaction was electro-transformed into DH5 αcells as suggested (BTX, San Diego, CA, USA).
To identify recombinant clones from each transformation, white bacterial colonies were picked with a sterile pipet tip, patched onto an LB master plate containing 100 µ g/mL ampicillin, 20 µ g/mL isopropyl-β -D -thiogalac - The two XcmI sites are underlined, and the two T overhangs generated by cleavage with XcmI are indicated in bold.
